
    
      Exfoliation glaucoma patients with significant cataracts are being informed about the study
      and potential risks, all patients giving written informed consent will undergo screening to
      determine eligibility for study entry. PatientÂ´s glaucoma is classified into stable or
      unstable glaucoma groups with their current glaucoma medication. Patients meeting the
      eligibility requirements of stable glaucoma will be randomised to cataract surgery combined
      with iStent (65 patients), II SLT (65 patients) or III cataract surgery alone (25 patients)
      and patient with unstable glaucoma will be randomised to cataract surgery combined with I
      iStent (65 patients), II SLT (65 patients).
    
  